| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
AVAGE (tazarotene) Cream, 0.1%, Allergan, NDA 21-184/S-002 Tazorac (tazarotene) Cream, 0.05% & 0.1%, Allergan NDA 21-184 9/29/00 10/10/00 10/16/00 Tazorac (tazarotene) Cream, 0.1%, Allergan NDA 21-184/S1 10/24/01 11/6/01 11/6/01 12/12/01 Indication: Treatment for Plaque Psoriasis. Tazorac (tazarotene) Gel, Allergan |
|
© 2009 Betterchem.com
|